All News

Filter News

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
|
NHLBI in the Press
Two studies partly funded by NHLBI have shown remarkable results in the treatment of patients with cystic fibrosis who also have at least one copy of the Phe508del CFTR, the most common CF-causing mutation.
|
NHLBI in the Press
Researchers have struggled to capture how mitochondrial DNA escapes the mitochondria—the energy powerhouse—in living cells. But now, a study published in the journal Science, provides an understanding of this process and could explain how inflammation occurs in autoimmune diseases.
|
NHLBI in the Press
Researchers are reporting discovery of a previously unidentified autoinflammatory disorder that triggers mysterious fevers every few weeks. They found that the disorder involves mutations in the RIPK1 gene, which makes a key protein in the mediation of cell death and inflammation.
|
NHLBI in the Press
The latest study conducted by NHLBI’s Prevention and Early Treatment of Acute Lung Injury (PETAL) Network concluded that administering high doses of vitamin D does not reduce mortality or morbidity in critically ill patients with vitamin D deficiencies.
|
NHLBI in the Press
Directly injecting living or dead heart stem cells into injured hearts and surrounding injured tissue triggers acute inflammation and wound healing-like properties in mice, according to a new study in Nature.
|
NHLBI in the Press
Researchers identified mutations in the PfCRT protein, found in the malaria parasite’s digestive compartment, as the source of resistance to the frontline malaria drug piperaquine (or PPQ). Malaria affects over 200 million people every year around the globe.
|
NHLBI in the Press
Fifty years of advancement into an ever-greater understanding of lung illnesses have whet the interest of the NHLBI’s Division of Lung Diseases (DLD) in precision medicine.
|
NHLBI in the Press
Teens with a single ventricle heart defect significantly improved their capacity to sustain moderate exercise by taking an oral medication. The trial results, researchers say, represent a milestone in the care for those who have undergone the Fontan procedure, a palliative operation for this patient
|
NHLBI in the Press
Researchers from dozens of leading institutions around that nation have proposed new criteria for diagnosing chronic obstructive pulmonary disease (COPD), the fourth leading cause of death in the United States.